BlackRock Fund Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$60K	Buy	552 +26	+5%	+$2.83K	﹤0.01%	3718
2016 Q3	$84K	Buy	526 +85	+19%	+$13.6K	﹤0.01%	3651
2016 Q2	$54K	Buy	+441	New	+$54K	﹤0.01%	3805